SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Schmitt Ulms G)
 

Sökning: WFRF:(Schmitt Ulms G) > The G51D SNCA mutat...

The G51D SNCA mutation generates a slowly progressive alpha-synuclein strain in early-onset Parkinson's disease

Lau, Heather H. C. (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.;Univ Toronto, Dept Biochem, Toronto, ON, Canada.
Martinez-Valbuena, Ivan (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.
So, Raphaella W. L. (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.;Univ Toronto, Dept Biochem, Toronto, ON, Canada.
visa fler...
Mehra, Surabhi (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.
Silver, Nicholas R. G. (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.;Univ Toronto, Dept Biochem, Toronto, ON, Canada.
Mao, Alison (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.;Univ Toronto, Dept Biochem, Toronto, ON, Canada.
Stuart, Erica (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.
Schmitt-Ulms, Cian (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.
Hyman, Bradley T. (författare)
Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA.;Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA.;Harvard Med Sch, Neurosci Program, Boston, MA USA.
Ingelsson, Martin (författare)
Uppsala universitet,Geriatrik,Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.; Univ Hlth Network, Krembil Brain Inst, Toronto, ON, Canada.;Univ Toronto, Dept Med, Toronto, ON, Canada.
Kovacs, Gabor G. (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.;Univ Hlth Network, Krembil Brain Inst, Toronto, ON, Canada.;Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
Watts, Joel C. (författare)
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.;Univ Toronto, Dept Biochem, Toronto, ON, Canada.
visa färre...
Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada;Univ Toronto, Dept Biochem, Toronto, ON, Canada. Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada. (creator_code:org_t)
BioMed Central (BMC), 2023
2023
Engelska.
Ingår i: Acta neuropathologica communications. - : BioMed Central (BMC). - 2051-5960. ; 11:1
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Unique strains of a-synuclein aggregates have been postulated to underlie the spectrum of clinical and pathological presentations seen across the synucleinopathies. Whereas multiple system atrophy (MSA) is associated with a predominance of oligodendroglial a-synuclein inclusions, a-synuclein aggregates in Parkinson's disease (PD) preferentially accumulate in neurons. The G51D mutation in the SNCA gene encoding a-synuclein causes an aggressive, early-onset form of PD that exhibits clinical and neuropathological traits reminiscent of both PD and MSA. To assess the strain characteristics of G51D PD a-synuclein aggregates, we performed propagation studies in M83 transgenic mice by intracerebrally inoculating patient brain extracts. The properties of the induced a-synuclein aggregates in the brains of injected mice were examined using immunohistochemistry, a conformational stability assay, and by performing a-synuclein seed amplification assays. Unlike MSA-injected mice, which developed a progressive motor phenotype, G51D PD-inoculated animals remained free of overt neurological illness for up to 18 months post-inoculation. However, a subclinical synucleinopathy was present in G51D PD-inoculated mice, characterized by the accumulation of a-synuclein aggregates in restricted regions of the brain. The induced a-synuclein aggregates in G51D PD-injected mice exhibited distinct properties in a seed amplification assay and were much more stable than those present in mice injected with MSA extract, which mirrored the differences observed between human MSA and G51D PD brain samples. These results suggest that the G51D SNCA mutation specifies the formation of a slowly propagating a-synuclein strain that more closely resembles a-synuclein aggregates associated with PD than MSA.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

Parkinson's disease
Multiple system atrophy
alpha-synuclein
Protein aggregation
Strain
Propagation
Transgenic mice
Neuropathology
Seed amplification assay

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy